{"id":"tp-58338","type":"article-newspaper","title":"Moleculin Biotech Cuts Third-Quarter Net Loss 74% to $6.5 Million","author":"John Kim","publisher":"TOKENPOST Inc.","url":"https://www.tokenpost.com/news/business/58338","datePublished":"2026-11-16T12:51:09.000Z","dateModified":"2026-11-16T12:51:09.000Z","language":"en","abstract":"Research and development expenses increased 20% to $4.5 million. The company had $7.3 million in cash and cash equivalents at Sept. 30, 2026.","section":"Business","references":[]}